We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.3%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$200M
AUM Growth
+$5.58M
(+2.9%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-3.02%
Top 10 Holdings %
Top 10 Hldgs %
67.62%
Holding
34
New
6
Increased
1
Reduced
2
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wynn Resorts
WYNN
|
+$8.06M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$7.34M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$6.84M |
| 4 |
Oscar Health
OSCR
|
+$5.73M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$3.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$22.4M |
| 2 |
TSMC
TSM
|
+$9.01M |
| 3 |
DexCom
DXCM
|
+$3.28M |
| 4 |
HLVX
HilleVax
HLVX
|
+$2.03M |
| 5 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$1.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.15% |
| 2 | Consumer Discretionary | 15.94% |
| 3 | Technology | 12.99% |
| 4 | Financials | 9.79% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Uber
UBER
$143B
| $22.7M | 11.33% |
301,457
| – | – |
|
2
Morgan Stanley
MS
$332B
| $19.6M | 9.79% |
187,714
| – | – |
|
3
Vertex Pharmaceuticals
VRTX
$121B
| $19.1M | 9.55% |
41,050
| – | – |
|
4
Teva Pharmaceuticals
TEVA
$40.9B
| $17.7M | 8.84% |
981,000
| – | – |
|
5
Alnylam Pharmaceuticals
ALNY
$27.1B
| $10.2M | 5.09% |
37,022
| – | – |
|
6
Pfizer
PFE
$143B
| $10.1M | 5.07% |
350,500
| – | – |
|
7
Bausch + Lomb
BLCO
$5.95B
| $9.77M | 4.89% |
506,343
| – | – |
|
|
8
Wynn Resorts
WYNN
$10.3B
| $9.61M | 4.81% |
+100,200
| New | +$8.06M |
|
|
9
Oscar Health
OSCR
$9.51B
| $8.78M | 4.39% |
413,800
+318,100
| +332% | +$5.73M |
|
|
10
VanEck Gold Miners ETF
GDX
$22.7B
| $7.72M | 3.86% |
+193,900
| New | +$7.34M |
|
11
Melco Resorts & Entertainment
MLCO
$2.26B
| $7.66M | 3.83% |
983,694
| – | – |
|
|
12
Bristol-Myers Squibb
BMY
$133B
| $7.54M | 3.77% |
+145,762
| New | +$6.84M |
|
13
Bath & Body Works
BBWI
$4.05B
| $7.08M | 3.54% |
221,902
| – | – |
|
14
Caesars Entertainment
CZR
$6.06B
| $6.16M | 3.08% |
147,625
| – | – |
|
15
Geron
GERN
$808M
| $6.07M | 3.04% |
1,338,084
| – | – |
|
16
Xenon Pharmaceuticals
XENE
$6.1B
| $5.78M | 2.89% |
146,800
| – | – |
|
|
SWTX
17
DELISTED
SpringWorks Therapeutics
SWTX
| $4.63M | 2.32% |
144,526
| – | – |
|
|
18
iShares Bitcoin Trust
IBIT
$46.7B
| $3.91M | 1.96% |
+108,200
| New | +$3.76M |
|
19
Alphabet (Google) Class A
GOOGL
$4.33T
| $2.31M | 1.15% |
13,900
| – | – |
|
20
Quanterix
QTRX
$164M
| $2.01M | 1% |
154,900
| – | – |
|
21
Edgewise Therapeutics
EWTX
$4.19B
| $1.99M | 1% |
+74,700
| New | +$1.49M |
|
22
Microsoft
MSFT
$3.44T
| $1.82M | 0.91% |
4,230
| – | – |
|
|
CPRX
23
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.8M | 0.9% |
90,651
-93,876
| -51% | -$1.74M |
|
24
Savara
SVRA
$1.11B
| $1.6M | 0.8% |
+376,800
| New | +$1.66M |
|
25
Toast
TOST
$18.8B
| $1.49M | 0.75% |
52,692
| – | – |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2024 Portfolio in Review
As of Q3 2024, Bridger Management held 34 positions worth $200M, up 2.9% from $194M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Bridger Management withdrew a net $6.04M in Q3 2024, closing 5 positions and reducing 2 holdings. Its most notable exit was Eli Lilly, an estimated $22.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 59% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Bridger Management opened a new position in Wynn Resorts worth $9.61M.
- Bridger Management's largest Q3 2024 buy was Wynn Resorts: 100,200 shares worth $9.61M.
- Bridger Management added most to Oscar Health in Q3 2024, an estimated $5.73M increase.
- Bridger Management's biggest Q3 2024 reduction was Catalyst Pharmaceutical, cutting an estimated $1.74M.
- Bridger Management fully exited Eli Lilly in Q3 2024, selling an estimated $22.4M.
- Bridger Management's ten largest holdings make up 68% of its $200M portfolio in Q3 2024.
- Bridger Management opened 6 new positions and closed 5 in Q3 2024.
- Bridger Management's portfolio value rose 2.9% quarter-over-quarter to $200M.
Based on Bridger Management's 13F filing for Q3 2024, filed 14 Nov 2024.